Functional characterization of GPIIb- and GPIIIa-specific monoclonal antibodies. Further evidence for the existence of agonist-specific activated states of the platelet fibrinogen receptor

By Castellarnau Conxita De   Cullare Cristina   Alvarez Maria V.   Muniz-Diez Eduardo   Calzada Maria J.   Gonzalez-Rodriguez Jose  

Platelets, Vol. 8, Iss. 4, 1997-07 ,pp. : 243-254

Informa Healthcare

Access to resources Recommend Favorite

Flow cytometric analysis of agonist-induced annexin V, factor Va and factor Xa binding to human platelets

By Dormann J. Kardoeus R. E. Zimmermann B. Kehrel D.  

Platelets, Vol. 9, Iss. 3-4, 1998-07 ,pp. : 171-177

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA-21 inhibits toll-like receptor 2 agonist–induced lung inflammation in mice

By Case Stephanie R.   Martin Richard J.   Jiang Di   Minor Maisha N.   Chu Hong Wei  

Experimental Lung Research, Vol. 37, Iss. 8, 2011-09 ,pp. : 500-508

Informa Healthcare

Access to resources Recommend Favorite

Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonist

By Bostwick J.S.   Kasiewski C.J.   Chu V.   Klein S.I.   Sabatino R.D.   Perrone M.H.   Dunwiddie C.T.   Cook J.J.   Leadley R.J.  

Thrombosis Research, Vol. 82, Iss. 6, 1996-06 ,pp. : 495-507

Elsevier

Access to resources Recommend Favorite

Oral Antiplatelet Efficacy of the Platelet GPIIb/IIIa Antagonist, DMP754 in Non-Human Primates - Receptor binding affinity & specificity

By Mousa S.A.   Bozarth J.   Youssef A.   Levine B.  

Thrombosis Research, Vol. 89, Iss. 5, 1998-03 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite